{"id":316321,"date":"2020-02-06T17:00:57","date_gmt":"2020-02-07T01:00:57","guid":{"rendered":"https:\/\/nai500.com\/blog\/2020\/02\/akesobio-files-for-300-million-hong-kong-ipo-to-develop-antibody-portfolio\/"},"modified":"2020-02-06T19:18:55","modified_gmt":"2020-02-07T03:18:55","slug":"%e4%b8%ad%e5%b1%b1%e5%ba%b7%e6%96%b9%e7%94%9f%e7%89%a9%e7%94%b3%e8%ab%8b%e9%a6%99%e6%b8%af%e4%b8%8a%e5%b8%82%e6%97%a8%e5%9c%a8%e9%96%8b%e7%99%bc%e6%8a%97%e9%ab%94%e7%94%a2%e5%93%81%e7%b5%84%e5%90%88","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hant\/blog\/2020\/02\/%e4%b8%ad%e5%b1%b1%e5%ba%b7%e6%96%b9%e7%94%9f%e7%89%a9%e7%94%b3%e8%ab%8b%e9%a6%99%e6%b8%af%e4%b8%8a%e5%b8%82%e6%97%a8%e5%9c%a8%e9%96%8b%e7%99%bc%e6%8a%97%e9%ab%94%e7%94%a2%e5%93%81%e7%b5%84%e5%90%88\/","title":{"rendered":"\u4e2d\u5c71\u5eb7\u65b9\u751f\u7269\u7533\u8acb\u9999\u6e2f\u4e0a\u5e02\uff0c\u65e8\u5728\u958b\u767c\u6297\u9ad4\u7522\u54c1\u7d44\u5408"},"content":{"rendered":"<p>\u4e2d\u5c71\u65b0\u578b\u85e5\u7269\u7814\u767c\u751f\u7269\u88fd\u85e5\u516c\u53f8\u2014\u2014\u4e2d\u5c71\u5eb7\u65b9\u751f\u7269\u7533\u8acb\u5728\u9999\u6e2f\u9032\u884c$3\u5104\u7684IPO\uff0c\u4ee5\u958b\u767c\u5176\u65b0\u578b\u55ae\u7279\u7570\u6027\u548c\u96d9\u7279\u7570\u6027\u6297\u9ad4\u7522\u54c1\u7d44\u5408\u3002 \u4e2d\u5c71\u5eb7\u65b9\u751f\u7269\u5df2\u7d93\u5efa\u7acb\u4e8618\u7a2e\u55ae\u514b\u9686\u6297\u9ad4\u7d44\u5408\uff0c\u9019\u4e9b\u7d44\u5408\u8655\u65bcCMC\u6216\u81e8\u5e8a\u958b\u767c\u968e\u6bb5\uff0c\u7528\u65bc\u816b\u7624\u5b78\u3001\u708e\u75c7\u3001\u81ea\u8eab\u514d\u75ab\u6027\u75be\u75c5\u548c\u5fc3\u8840\u7ba1\u75be\u75c5\u3002 \u4e2d\u5c71\u5eb7\u65b9\u751f\u7269\u901a\u5e38\u4f7f\u7528PD-1\u6297\u9ad4\u4f5c\u70ba\u9aa8\u67b6\u4f86\u958b\u767c\u96d9\u7279\u7570\u6027\u6297\u9ad4\u3002 \u53bb\u5e74\u5e95\uff0c\u4e2d\u5c71\u5eb7\u65b9\u751f\u7269\u5b8c\u6210\u4e86\u7531\u6b63\u5fc3\u8c37\u5275\u65b0\u8cc7\u672c\u548c\u4e2d\u570b\u751f\u7269\u88fd\u85e5\u727d\u982d\u7684$1.5\u5104D\u8f2a\u878d\u8cc7\u3002<\/p>\n<p>\u82f1\u6587\u4f86\u6e90\uff1aChina Biotoday<\/p>\n","protected":false},"excerpt":{"rendered":"<p>AkesoBio, a Zhongshan novel drug discovery, filed for a $300 million Hong Kong IPO to develop its portfolio of novel mono- and bi-specific antibodies.<\/p>\n","protected":false},"author":9,"featured_media":316306,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[426],"tags":[927,563,644,564],"class_list":["post-316321","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hant","tag-927","tag--zh-hant","tag-644","tag-564","sectors-life-science-zh-hant","locations-china-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/316321","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=316321"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/316321\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/316306"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=316321"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=316321"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=316321"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}